CBD drinks brand Trip has made headlines recently for its ambitious global expansion strategy, albeit racking up significant losses of nearly £14 million. The burgeoning company, founded in 2019 by Olivia Ferdi and Dan Khoury, incurred £5.6 million in losses in the financial year ending 28 February 2024, continuing a trend from the previous year. While the unaudited accounts do not disclose specific revenues, Trip is rumoured to be on track for impressive sales, with expectations to exceed £60 million within the calendar year.

Despite these financial setbacks, Trip has not seen its growth stymied. According to reports, it has demonstrated remarkable progress, becoming the fastest-growing soft drink brand in the UK. NielsenIQ data shows that Trip's value sales surged by a staggering 522%, reaching £4.3 million over a one-year period. The brand now claims to dominate the UK CBD drinks market, allegedly holding an 88% share, although this figure is based on a subset of sales captured by NielsenIQ, which represents less than 20% of its total revenue.

Trip’s expansion into the US marketplace has been particularly noteworthy. As a component of its strategy, the brand has fortified its distribution channels and established itself with major US retail giants, including Target and Sprouts Farmers Market. With plans to further bolster its US presence, Trip is also working to expand into three additional national accounts by the first quarter of 2026. The integration of a manufacturing base in the US marks a significant step for the brand, allowing it to serve a rapidly growing customer base effectively.

In addition to its core revenue-generating operations, the brand has secured substantial investment, garnering over £25 million through various funding rounds. Noteworthy backers include Maria Raga, the former CEO of Depop, and Christian Angermayer, founder of Apeiron Investment Group. This financial support has been pivotal for Trip as it enables the company to solidify its infrastructure across the globe while continuing to innovate within the wellness sector.

With its UK operations turning a profit and the brand consistently topping lists of fastest-growing companies, Trip remains optimistic about its future. Managing Director James Edmunds emphasised the company's mission to help people find calm around the world, stating, “Since launch in 2019, we have invested to build a global brand.” The anticipated continuation of rapid growth aims to see revenue exceed £100 million by 2026, as Trip positions itself at the forefront of the booming CBD market.

As conversations about mental wellbeing evolve and the stigma around CBD diminishes, Trip appears poised not merely for survival but for a significant leadership role in an industry projected to reach new heights. The road ahead may be peppered with challenges, but with an engaged community and a strong market presence, Trip continues its journey towards becoming a household name.


Reference Map

  1. Paragraphs 1, 2
  2. Paragraphs 3, 4
  3. Paragraphs 3, 4
  4. Paragraph 5
  5. Paragraph 5
  6. Paragraph 3
  7. Paragraph 3

Source: Noah Wire Services